Literature DB >> 32276825

The role of inflammation in stress cardiomyopathy.

Andra Maria Ciutac1, Dana Dawson2.   

Abstract

Stress cardiomyopathy (SC) is an increasingly recognized form of acute heart failure, which has been linked to a wide variety of emotional and physical triggers. The pathophysiological mechanisms of the disease remain incompletely understood, however, inflammation has been recently shown to play a pivotal role. This review summarizes the most notable findings of myocardial inflammation, demonstrated from biopsies and cardiac magnetic resonance imaging in humans. In the acute stage macrophage infiltration appears to represent the substrate for myocardial edema, together defining the local myocardial inflammation. This appears to evolve into a low grade systemic chronic inflammation which could explain the protracted clinical course of these patients and raises hope for finding a specific SC cardiac biomarker as well as a therapeutic breakthrough. As a parallel to the human findings the review covers some of the emerging mechanistic insights from experimental models, which, albeit not proven in the human condition, highlight the possible importance in pursuing distinct paths of investigation such as the beta-receptor signaling, aberrations of nitric oxide generation and signaling and the contribution of the vascular endothelium/permeability to edema and inflammation during the acute stage.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiac magnetic; Inflammation; Resonance imaging; Takotsubo cardiomyopathy

Year:  2020        PMID: 32276825     DOI: 10.1016/j.tcm.2020.03.005

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  6 in total

Review 1.  Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.

Authors:  Agapios Sachinidis
Journal:  Cells       Date:  2020-04-17       Impact factor: 6.600

2.  The Impact of COPD on in-Hospital Outcomes in Patients with Takotsubo Cardiomyopathy.

Authors:  Pengyang Li; Xiaojia Lu; Catherine Teng; Peng Cai; Mark Kranis; Qiying Dai; Bin Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-29

Review 3.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

4.  Case Report: Steroid-Responsive Takotsubo Cardiomyopathy Associated With Cytokine Storm and Obstructive Shock.

Authors:  Brent Gudenkauf; Michael R Goetsch; Rachit M Vakil; Oscar Cingolani; Luigi Adamo
Journal:  Front Cardiovasc Med       Date:  2022-07-11

5.  Stress-Induced Cardiomyopathy Secondary to COVID-19.

Authors:  Aneesh Bapat; Abhishek Maan; E Kevin Heist
Journal:  Case Rep Cardiol       Date:  2020-08-24

6.  Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries.

Authors:  Kai M Eggers; Tomasz Baron; Marcus Hjort; Anna M Nordenskjöld; Per Tornvall; Bertil Lindahl
Journal:  Clin Cardiol       Date:  2021-05-25       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.